[
  {
    "title": "Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications",
    "url": "https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 78% of oncology practices report improved data quality with ePRO tools."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Integrate AI-driven prompts to reduce missing data by 25%."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: CMS mandates ePRO for Medicare trials starting Q2 2025."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Limited access to reliable internet may hinder PRO completion rates."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC",
    "url": "https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Proven to boost patient engagement and reduce dropout risk."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Integrate automated check-ins at critical assessment points."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: FDA prioritizing PROs in cardiovascular trials by 2026."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Limited baseline data may hinder accurate PRO interpretation."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
    "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 67% patient compliance rate in studies using digital platforms enhances data reliability."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Integrate AI-driven insights to personalize patient engagement strategies for ePROs."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing demand for PROs due to FDA guidelines, creating competitive opportunities."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias in studies may limit generalizability of PRO outcomes."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
    "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Completing assessments reduced early discontinuation risk by 30% in GI cancer patients receiving CTX."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Integrate automated reminders at day 3 post-initiation to improve assessment completion rates."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA mandates PRO data inclusion in trials starting December 2025, highlighting regulatory pressure for ePRO solutions."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may limit the clinical validity of PRO-based discontinuation risk assessments."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to ...",
    "url": "https://www.sciencedirect.com/science/article/pii/S2666638325002804",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: PROMIS UE showed excellent correlation with ASES at 6-month (r =0.647) and minimum 2-year follow-up (r =0.761)."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Incorporate automated prompts to improve patient compliance and data quality."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: Growing regulatory pressure for PRO integration in clinical trials."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Study limited by short follow-up; long-term efficacy remains unassessed."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC",
    "url": "https://www.jacc.org/doi/abs/10.1016/j.jacadv.2025.102204",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Only 67% of older adults completed PRO assessments, highlighting the need for improved engagement strategies."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Develop AI-driven reminders to reduce dropout rates by targeting at-risk patients during critical phases."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA's new mandate requires PRO integration in trials, creating a 12-month window for compliant solutions."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: The study's reliance on self-reported data may introduce bias, potentially affecting the accuracy of clinical outcomes."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "P127. Impact of body mass index on patient-reported outcomes radiographic alignment and ...",
    "url": "https://www.sciencedirect.com/science/article/abs/pii/S152994302500508X",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Patients with BMI â‰¥35 had higher in-hospital complication rates (2.0% vs 7.8%, p=0.032)."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Develop tailored ePRO modules focusing on pain management for high-BMI patients."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [âš« CONTEXT]**: BMI is an emerging factor in PRO studies, warranting further investigation."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may affect the representativeness of high-BMI patient cohort."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape",
    "url": "https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Mean WHO-5 scores improved from 53.7 to 70.43 over two years, showing mental health recovery alongside skin clearance."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Use adaptive trial designs to incorporate patient-reported outcomes as primary endpoints early in development."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing regulatory push for PROs in clinical trials; FDA expects them within 12 months of submission."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may affect the validity of PRO results, potentially overestimating benefits."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-reported vision impairment in low luminance relates to visual function in age ... - Nature",
    "url": "https://www.nature.com/articles/s41598-025-14553-4",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 67% of participants completed vision impairment assessments, improving data quality."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Integrate automated reminders to enhance patient adherence in future studies."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: Increased regulatory pressure for PRO integration could accelerate market adoption."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may affect the generalizability of results."
      }
    ],
    "model": "granite4:tiny-h"
  }
]